NCT00307450View on ClinicalTrials.gov

Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2009

Conditions
Parkinson's Disease
Interventions
DRUG

Levetiracetam

up to 200 mg per day in two dosages per day.

Trial Locations (2)

01307

Department of Neurology at the Technical University of Dresden, Dresden

04103

Department of Neurology at the University of Leipzig, Leipzig

All Listed Sponsors
collaborator

UCB Pharma GmbH

INDUSTRY

lead

Technische Universität Dresden

OTHER

NCT00307450 - Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease | Biotech Hunter | Biotech Hunter